Health spending has started to rise again after stagnating or even falling in many Organization for Economic Cooperation and Development (OECD) countries during the crisis, but the pace of growth remains well below pre-crisis rates, especially in Europe, according to OECD Health Statistics 2014.
In Europe, health spending continued to fall in 2012 in Greece, Italy, Portugal and Spain, as well as in the Czech Republic and Hungary. In Greece, health spending in real terms was 25% lower in 2012 than in 2009, primarily driven by cuts in public spending.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze